Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies-Reference-Cited by-同舟云学术

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies

Published:2021-06-23 Issue:7 Volume:5 Page:
ISSN:2473-4039
Container-title:JBMR Plus
language:en
Short-container-title:JBMR Plus

Author:

Rodríguez Alexander J¹²^ORCID,Abrahamsen Bo³⁴^ORCID

Affiliation:

1. Bone and Muscle Health Research Group, Department of Medicine, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences Monash University, Monash Medical Centre Clayton Victoria Australia

2. Disorders of Mineralisation Research Group, School of Medical and Health Sciences Edith Cowan University Joondalup Western Australia Australia

3. Department of Medicine Holbæk Hospital Holbæk Denmark

4. Odense Patient Data Explorative Network (OPEN) University of Southern Denmark Odense Denmark

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbm4.10522

Reference88 articles.

1. Diagnosis of osteoporosis and assessment of fracture risk

2. Mortality after all major types of osteoporotic fracture in men and women: an observational study

3. WattsJJ Abimanyi‐OchomJ SandersKM. Osteoporosis costing all Australians: a new burden of disease analysis – 2012 to 2022. Analysis and Policy Observatory; 2013. Available from:https://apo.org.au/node/37062. Accessed June 14 2021.

4. Arterial calcification: A new perspective?

5. Exploring the Links Between Common Diseases of Ageing—Osteoporosis, Sarcopenia and Vascular Calcification

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiosteoporosis medications and cardiovascular disease: a population-based nationwide nested case–control study;Frontiers in Pharmacology;2023-10-10

2. Comparison of Cardiovascular Events among Users of Different Classes of Anti-Osteoporosis Medications;INT J GERONTOL;2023

3. Long-term and sequential treatment for osteoporosis;Nature Reviews Endocrinology;2023-07-18

4. Association between bisphosphonate use and stroke risk: a meta-analysis;Osteoporosis International;2023-05-30

5. Evidence for the cardiovascular effects of osteoporosis treatments in randomized trials of post-menopausal women: A systematic review and Bayesian network meta-analysis;Bone;2023-02